| para‐Nitroblebbistatin, the Non‐Cytotoxic and Photostable Myosin II Inhibitor M Képiró, BH Várkuti, L Végner, G Vörös, G Hegyi, M Varga, ... Angewandte Chemie International Edition 53 (31), 8211-8215, 2014 | 137 | 2014 |
| A highly soluble, non-phototoxic, non-fluorescent blebbistatin derivative BH Várkuti, M Képiró, IÁ Horváth, L Végner, S Ráti, Á Zsigmond, G Hegyi, ... Scientific reports 6 (1), 26141, 2016 | 125 | 2016 |
| A novel actin binding site of myosin required for effective muscle contraction BH Várkuti, Z Yang, B Kintses, P Erdélyi, I Bárdos-Nagy, AL Kovács, ... Nature structural & molecular biology 19 (3), 299-306, 2012 | 78 | 2012 |
| Azidoblebbistatin, a photoreactive myosin inhibitor M Képiró, BH Várkuti, A Bodor, G Hegyi, L Drahos, M Kovács, ... Proceedings of the National Academy of Sciences 109 (24), 9402-9407, 2012 | 50 | 2012 |
| Neuron-based high-content assay and screen for CNS active mitotherapeutics BH Varkuti, M Kepiro, Z Liu, K Vick, Y Avchalumov, R Pacifico, ... Science advances 6 (2), eaaw8702, 2020 | 30 | 2020 |
| High-throughput small molecule screen identifies modulators of mitochondrial function in neurons BH Varkuti, Z Liu, M Kepiro, R Pacifico, Y Gai, T Kamenecka, RL Davis IScience 23 (3), 2020 | 14 | 2020 |
| Structural model of weak binding actomyosin in the prepowerstroke state BH Várkuti, Z Yang, A Malnasi-Csizmadia Journal of Biological Chemistry 290 (3), 1679-1688, 2015 | 14 | 2015 |
| Molecular tattoo: subcellular confinement of drug effects M Képiró, BH Várkuti, AA Rauscher, MSZ Kellermayer, M Varga, ... Chemistry & biology 22 (4), 548-558, 2015 | 11 | 2015 |
| Effect of allosteric inhibition of non-muscle myosin 2 on its intracellular diffusion ÁI Horváth, M Gyimesi, BH Várkuti, M Képiró, G Szegvári, I Lőrincz, ... Scientific Reports 10 (1), 13341, 2020 | 9 | 2020 |
| High content, phenotypic assays and screens for compounds modulating cellular processes in primary neurons M Kepiro, BH Varkuti, RL Davis Methods in enzymology 610, 219-250, 2018 | 9 | 2018 |
| Water-soluble myosin 2 inhibitors for the treatment of neurological, neuropathic or psychiatric diseases Z Lenkei, AM CSIZMADIA, M Képiró, B Várkuti US Patent 10,858,357, 2020 | 2 | 2020 |
| A Novel Actin Binding Site of Myosin is Responsible for Effective Muscle Contraction B Varkuti, Z Yang, B Kintses, P Erdelyi, T Vellai, M Kellermayer, ... Biophysical Journal 100 (3), 130a-131a, 2011 | 1 | 2011 |
| New mechanism of actin activation of myosin B Varkuti, B Kintses, L Vegner, A Rauscher, MC Andras Biophysical Journal 96 (3), 493a-494a, 2009 | 1 | 2009 |
| Mitotherapeutics for the treatment of brain disorders RL Davis, Z Liu, BH Varkuti, M Kepiro, CM Macmullen US Patent App. 17/756,842, 2023 | | 2023 |
| The role of NM2 rearrangement during cytokinesis AI Horvath, M Gyimesi, M Kepiro, B Varkuti, A Malnasi-Csizmadia Biophysical Journal 121 (3), 259a-260a, 2022 | | 2022 |
| Molecular Tattoo: Subcellular Confinement of Drug Effects In Vivo with Two-Photon Microscopy B Várkuti, M Képiró, AÁ Rauscher, L Végner, Á Zsigmond, V Imrich, S Ráti, ... Biophysical Journal 112 (3), 149a-150a, 2017 | | 2017 |
| Subcellular Spatial Control of Non-Muscle Myosin 2 Redistribution and Stress Fiber Strain by Molecular Tattoo AI Horvath, BH Varkuti, M Kepiro, G Hegyi, M Kovacs, ... Biophysical Journal 112 (3), 430a, 2017 | | 2017 |
| Highly Soluble, Non-Phototoxic, Non-Fluorescent, Photostable Blebbistatin Derivatives AÁ Rauscher, S Kumar, BH Várkuti, M Képiró, ÁI Horváth, L Végner, ... Biophysical Journal 112 (3), 266a-267a, 2017 | | 2017 |
| Molecular Tattooing of Live Cells and Animals: Spatial and Time Specific Effects of Azidoblebbistatin by Two-Photon Microscopy M Kepiro, B Varkuti, G Hegyi, MSZ Kellermayer, MC Andras Biophysical Journal 106 (2), 177a, 2014 | | 2014 |
| Interactomics of Blebbistatin M Képiró, BH Várkuti, G Hegyi, M Kovács, A Málnási-Csizmadia Biophysical Journal 104 (2), 403a-404a, 2013 | | 2013 |
